Plain-English translation of NCT04081701 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Phase 4 — The treatment has already been approved. Researchers are tracking how it works in a large number of people over time.
This trial is testing a specialized imaging scan called 68-Ga DOTATATE PET/MRI to see if it can better help doctors find and monitor certain types of brain tumors. The scan combines two types of imaging — positron emission tomography (PET) and magnetic resonance imaging (MRI) — to create detailed pictures of the brain. Researchers want to see if this new scan can detect tumors that standard MRI might miss, and help patients who have already had surgery or radiation therapy.
Some brain tumors are hard to fully see with regular MRI scans, especially after surgery or radiation treatment. This study exists to learn whether the new imaging approach can help doctors spot tumor growth earlier and more accurately, which could improve how these tumors are treated and monitored over time.
You likely qualify if…
You likely don't qualify if…
You will come in for a specialized brain scan using the new 68-Ga DOTATATE PET/MRI imaging technology. The scan combines PET and MRI imaging to create detailed pictures of your brain and tumor. The visit will include the imaging procedure itself, which takes time to complete as you lie still in the scanner while detailed images are captured. Your participation helps doctors understand whether this new scan can better detect and monitor brain tumors.
AI-generated summary from trial data · Jun 4, 2026 · Not medical advice
United States